Publications by authors named "Lanjiao Zhai"
Article Synopsis
- * Researchers developed a new therapeutic agent, GB18-06, a GDF15-targeting nanobody that effectively inhibited the GDF15-GFRAL signaling pathway, which is involved in appetite suppression and energy balance.
- * In animal studies, GB18-06 successfully reduced weight loss by over 20% and increased physical activity by 77%, showing promise as a targeted treatment that could enhance the quality of life for cachexia patients.
